Neogenomics Stock Price. Everything You Need To Know About The Neogenomics Stock!
NeoGenomics, Inc. is a clinical laboratory company, which engages in cancer genetics diagnostic testing and pharma services. The company is headquartered in Fort Myers, Florida and currently employs 2,100 full-time employees. The company went IPO on 2012-12-10. The firm operates through two segments: the Clinical Services Segment and the Pharma Services Segment. The Clinical Services segment provides various clinical testing services to community-based pathology practices, oncology practices, hospital pathology labs, reference labs, and academic centers with reimbursement from various payers, including client direct billing, commercial insurance, Medicare and other government payers, and patients. The Pharma Services segment supports pharmaceutical firms in their drug development programs by providing testing services and data analytics for clinical trials and research. The firm offers testing services, which include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, immunohistochemistry (IHC) and digital imaging, molecular testing and morphologic analysis. The company operates testing laboratories in United States, Europe and Asia.
Neogenomics Stock Price. Everything You Need To Know About The Neogenomics Stock! performance -
Employees
2100 -
Company HQ
Fort Myers -
Website
https://neogenomics.com/ -
NEO Asset Type
Common Stock -
NEO Market Capitalization
1.8B - Earnings Per Share -0.7
- Dividends Per Share None
- Dividend Date None
- Quarterly Earnings Growth 1.306
Employees
2100Company HQ
Fort MyersWebsite
https://neogenomics.com/NEO Asset Type
Common StockNEO Market Capitalization
1.8BNeogenomics is a leading provider of cancer-focused genetic testing services, catering to both physicians and pharmaceutical companies. With its extensive portfolio of cutting-edge diagnostic tests, Neogenomics aims to guide personalized treatment decisions and enable targeted therapies for patients battling cancer. If you’re a retail investor from Malaysia, Thailand, Indonesia, or Vietnam looking to invest in this promising stock, you’ve come to the right place. At Zorion, we not only offer a convenient platform to invest in real US stocks like Neogenomics but also provide investment insights and recommendations to help you make informed decisions. Gain access to educational resources and expand your investment knowledge. Start investing in Neogenomics today with Zorion.
